M
Mark McClure
Forest Health Specialist at Georgia Forestry Commission, based in Albany, Georgia
2
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
Aug 14, 2026
A spotlight on vasculitis and the kidneys
14:52
42:27

Ashley ElliottHOST
Just if we talk about the, um, the trial data that supports its use and its place then in practice, and then kind of just talking about, um, recent safety reviews of its treatment, uh, where, where do you see avacopan's place in treatment at the moment?
M
15:08Mark McClureGUEST
So this is a, this is a hot topic, Ash, as, at, at, at, at the moment, as, as you know.
M
15:14Mark McClureGUEST
Um, so, you know, I'll talk, talk about the data and then about the controversies.
M
15:17Mark McClureGUEST
So I guess let's go back several very convincing preclinical studies, um, showing the, the benefit of targeting that, um, C5A, uh, pathway in patients with ANCA vasculitis and lots of different groups, um, showing, showing, showing benefit.
M
15:39Mark McClureGUEST
Went on to clinical development, passed through phase one, two very positive phase two studies called CLEAR and CLASSIC, and then the phase three ADVOCATE trial, um, that was 330 patients randomized to receive avacopan or basically a, a standard pre- prednisolone taper that looked a lot like the reduced dose PEXEVAS, um, taper.
M
16:05Mark McClureGUEST
The clinician could decide whether they gave rituximab or, or cyclophosphamide, and essentially they showed no difference, uh, in terms of remission, uh, at week 26, but then significantly more patients in sustained remission at week 52, uh, in the avacopan arm, which was a 12.5% point difference.
26 MINS LATER

Ashley ElliottHOST
Um, so just, um, just to finish him off, just where do you see, uh, the future going in terms of emerging therapies in vasculitis?
27. The Silent Spread: Georgia’s Fight Against Cogongrass with Paul McDaniel & Mark McClure
M
1:40Mark McClureGUEST
Paul, cogongrass is ranked as one of the top 10 worst weeds in the entire world, not just the US, but the entire world.
M
1:56Mark McClureGUEST
It greens up early in the growing season, one of the first grasses to green up, and the only warm-season grass in this area of the state or this area, period, that flowers in the springtime.
M
2:14Mark McClureGUEST
What does that tell us? The imperata was named after the Italian botanist, Ferrante Imperata.
11 MINS LATER
P
13:12Paul McDanielHOST
If you have cogongrass spread in those areas, you can really scorch a lot of your trees with that heavy fire intensity.